Phenylephrine from BASF relieves runny noses, coughs and sore throats

* Active drug substance soothes the nasal passages and airways

Ludwigshafen , Germany. – The BASF portfolio has a new addition: phenylephrine hydrochloride. The well-established substance provides fast, effective relief for runny noses. In nasal sprays, phenylephrine helps nasal membranes to decongest. They secrete less mucus as a result, and the blocked nose clears.

“The offering is BASF’s response to increased demand for this tried and tested pharmaceutical ingredient. Phenylephrine is particularly popular in the USA, the world’s largest market for cold remedies,” says Brigitte Sebastian, head of global marketing for active pharmaceutical ingredients at BASF.



BASF’s latest addition to the portfolio strengthens its position on the global market for cold remedies. P henylephrine hydrochloride is produced at BASF’s site in Minden, Germany. The product is ideally suited to the plants and technologies already in place at Minden, so building on high quality and reliable supply. BASF has recourse to more than 50 years of experience in active pharmaceutical ingredient production. The pharmaceutical site also meets all cGMP (current Good Manufacturing Practice) guidelines and FDA (Food and Drug Administration/US regulatory authority) requirements. As a reliable partner to the pharmaceutical industry, BASF guarantees product quality and safety.